Telegraft Editorial Board

 

The Telegraft is the leading global cell therapy newsletter. It is provided as a benefit of ISCT membership online. It is also used as a promotional vehicle for ISCT activities. This bi-monthly e-newsletter includes insightful discussions and up-to-date information on critical issues affecting the field of cellular therapy.

The Telegraft provides those in or interested in the cell therapy community with current information on new developments, items of interest, regulatory updates, and regular columns on related meetings, organizations and events, summaries of work being done in both academic and industry labs around the world, and much more. Special issues are also published as required to cover developments of particular importance or interest to the membership. 

 For the 2016 Telegraft Submission Deadline and Release Schedule, as well as for information on how to submit articles and article suggestions to Telegraft, please click here.

 

Click here for the ISCT members-only Telegraft Archive



 

Editorial Board:

 


 

Deborah Griffin, MSc, ASQ CPGP
Editor-in-Chief
Consultant
Pittsburgh, PA, United States



Russell Cruz, MD
Associate Editor
Children's National Medical Center
Washington, DC, United States
 
 Contributing Editors: 

Paul Eldridge, PhD
University of North Carolina
Chapel Hill, NC, United States
Janet Macpherson, PhD
Royal Prince Alfred Hospital
Sydney, Australia
Lynn O'Donnell, PhD
Contributing Editor and Telegraft Advisor
Ohio State University, James Cancer Hospital
Columbus, OH, United States
Michele Sugrue, MT
University of Florida
Gainesville, FL, United States                             
Wouter Van't Hoff, PhD
Cleveland Cord Blood Center
Cleveland, OH, United States





 

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.